Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing

Title: A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
Authors: Alioto, TS; Buchhalter, I; Derdak, S; Hutter, B; Eldridge, MD; Hovig, E; Heisler, LE; Beck, TA; Simpson, JT; Tonon, L; Sertier, AS; Patch, AM; Jäger, N; Ginsbach, P; Drews, R; Paramasivam, N; Kabbe, R; Chotewutmontri, S; Diessl, N; Previti, C; Schmidt, S; Brors, B; Feuerbach, L; Heinold, M; Gröbner, S; Korshunov, A; Tarpey, PS; Butler, AP; Hinton, J; Jones, D; Menzies, A; Raine, K; Shepherd, R; Stebbings, L; Teague, JW; Ribeca, P; Giner, FC; Beltran, S; Raineri, E; Dabad, M; Heath, SC; Gut, M; Denroche, RE; Harding, NJ; Yamaguchi, TN; Fujimoto, A; Nakagawa, H; Quesada, V; Valdés-Mas, R; Nakken, S; Vodák, D; Bower, L; Lynch, AG; Anderson, CL; Waddell, N; Pearson, JV; Grimmond, SM; Peto, M; Spellman, P; He, M; Kandoth, C; Lee, S; Zhang, J; Létourneau, L; Ma, S; Seth, S; Torrents, D; Xi, L; Wheeler, DA; López-Otín, C; Campo, E; Campbell, PJ; Boutros, PC; Puente, XS; Gerhard, DS; Pfister, SM; McPherson, JD; Hudson, TJ; Schlesner, M; Lichter, P; Eils, R; Jones, DTW; Gut, IG
Publisher Information: NATURE PORTFOLIO
Publication Year: 2015
Collection: The University of Melbourne: Digital Repository
Description: As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding of the variables affecting sequencing analysis output is required. Here using tumour-normal sample pairs from two different types of cancer, chronic lymphocytic leukaemia and medulloblastoma, we conduct a benchmarking exercise within the context of the International Cancer Genome Consortium. We compare sequencing methods, analysis pipelines and validation methods. We show that using PCR-free methods and increasing sequencing depth to ∼ 100 × shows benefits, as long as the tumour:control coverage ratio remains balanced. We observe widely varying mutation call rates and low concordance among analysis pipelines, reflecting the artefact-prone nature of the raw data and lack of standards for dealing with the artefacts. However, we show that, using the benchmark mutation set we have created, many issues are in fact easy to remedy and have an immediate positive impact on mutation detection accuracy.
Document Type: article in journal/newspaper
Language: English
ISSN: 2041-1723
Relation: pii: ncomms10001; https://hdl.handle.net/11343/258047
Availability: https://hdl.handle.net/11343/258047
Rights: https://creativecommons.org/licenses/by/4.0 ; CC BY
Accession Number: edsbas.993CF071
Database: BASE